Dual cytokine fusion proteins comprising IL-10
US11292822B2 · kind B2 · utility
18Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 11, 2021 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | Mar 11, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application relates to a dual cytokine fusion protein composition, pharmaceutical composition, and/or formulation thereof comprising IL-10 or IL-10 variant molecules fused to a single chain variable fragment scaffolding system and a second cytokine, where the second cytokine is linked in the hinge region of the scFv. The application also relates to methods of using the dual cytokine fusion protein composition for treating cancer, inflammatory diseases or disorders, and immune and immune mediated diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.